MedReleaf (LEAF)has notable insider net $ selling

MedReleaf (:LEAF)

Angelo Fefekos, a Senior Officer, disposed 695,339 Common Shares on a direct ownership basis at prices ranging from $25.180 and $25.700 through the public market between June 27th, 2018 and June 28th, 2018. The insider also acquired 220,528 Common Shares on a direct ownership basis at prices ranging from $2.960 and $9.500 through an exercise of options on June 28th, 2018. This represents a $16,412,304 net divestment of the company's shares and an account share holdings change of -100.0%.

Friedberg, a Senior Officer, acquired 42,846 Common Shares on a direct ownership basis at prices ranging from $0.000 and $9.500 through an exercise of options on June 29th, 2018. The insider also disposed 42,846 Common Shares on a direct ownership basis at prices ranging from $26.890 and $27.017 through the public market on June 29th, 2018. This represents a $880,112 net divestment of the company's shares and an account share holdings change of 0%.

Robert Gora, a Senior Officer, disposed 3,273 Common Shares on a direct ownership basis at a price of $29.310 through the public market on June 25th, 2018. This represents a $95,932 divestment of the company's shares and an account share holdings change of -100.0%.

Darren Anthony Karasiuk, a Senior Officer, disposed 39,022 Common Shares on a direct ownership basis at prices ranging from $26.613 and $26.890 through the public market on June 29th, 2018. The insider also acquired 29,022 Common Shares on a direct ownership basis at a price of $9.500 through an exercise of options on June 29th, 2018. This represents a $765,565 net divestment of the company's shares and an account share holdings change of -95.0%.

MedReleaf Corp is a Canada-based company which operates as a licensed producer of cannabis-based pharmaceutical products. The Company produces and sells its dried cannabis and cannabis oil products, including cannabis oil capsules. The Company produce an aggregate of up to 6,000 kilograms of dried cannabis and up to 1,760 kilograms of cannabis oil, and to sell and distribute within Canada an aggregate of up to 5,000 kilograms of dried cannabis, up to 1,319 kilograms of bottled cannabis oil, and up to 440 kilograms of encapsulated cannabis oil. The Company is an analytically-driven organization focused on patient care, scientific innovation, and advancing the understanding of the therapeutic benefits of cannabis.